Cyclerion Therapeutics, Inc. (CYCN)
NASDAQ: CYCN · Real-Time Price · USD
1.380
+0.030 (2.22%)
At close: Jan 22, 2026, 4:00 PM EST
1.370
-0.010 (-0.72%)
After-hours: Jan 22, 2026, 7:24 PM EST
Cyclerion Therapeutics Market Cap
Cyclerion Therapeutics has a market cap or net worth of $5.25 million as of January 22, 2026. Its market cap has decreased by -35.55% in one year.
Market Cap
5.25M
Enterprise Value
665.54K
1-Year Change
-35.55%
Ranking
Category
Stock Price
$1.38
Market Cap Chart
Since March 18, 2019, Cyclerion Therapeutics's market cap has decreased from $193.31M to $5.25M, a decrease of -97.28%. That is a compound annual growth rate of -40.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 21, 2026 | 5.14M | 6.30% |
| Dec 31, 2025 | 4.83M | -40.68% |
| Dec 31, 2024 | 8.15M | -0.51% |
| Dec 29, 2023 | 8.19M | -71.30% |
| Dec 30, 2022 | 28.54M | -61.69% |
| Dec 31, 2021 | 74.50M | -28.31% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Mar 18, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Adial Pharmaceuticals | 6.11M |
| Aspire Biopharma Holdings | 5.88M |
| Xenetic Biosciences | 5.76M |
| Can-Fite BioPharma | 5.64M |
| Indaptus Therapeutics | 5.64M |
| Revelation Biosciences | 5.48M |
| Decoy Therapeutics | 5.43M |
| VivoSim Labs | 5.35M |